142 related articles for article (PubMed ID: 17390059)
21. The detection of p53 gene mutation using a microdissection technique in primary intracranial germ cell tumors.
Kim SK; Cho BK; Paek SH; Hong SJ; Kim HS; Hong SY; Choe G; Chi JG; Nam DH; Wang KC
Int J Oncol; 2001 Jan; 18(1):111-6. PubMed ID: 11115546
[TBL] [Abstract][Full Text] [Related]
22. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
[TBL] [Abstract][Full Text] [Related]
23. The distribution and behavior of extragonadal primordial germ cells in Bax mutant mice suggest a novel origin for sacrococcygeal germ cell tumors.
Runyan C; Gu Y; Shoemaker A; Looijenga L; Wylie C
Int J Dev Biol; 2008; 52(4):333-44. PubMed ID: 18415933
[TBL] [Abstract][Full Text] [Related]
24. The p53 gene in soft tissue sarcomas: prognostic value of DNA sequencing versus immunohistochemistry.
Taubert H; Würl P; Bache M; Meye A; Berger D; Holzhausen HJ; Hinze R; Schmidt H; Rath FW
Anticancer Res; 1998; 18(1A):183-7. PubMed ID: 9568075
[TBL] [Abstract][Full Text] [Related]
25. TGF-betaRII, BAX, IGFIIR, caspase-5, hMSH3 and hMSH6 alterations are not associated with microsatellite instability or p53 mutations in invasive urothelial carcinoma of the urinary bladder.
Saetta AA; Korkolopoulou P; Karlou M; Levidou G; Goudopoulou A; Thymara I; Stamatelli A; Tzivras M; Michalopoulos NV; Thomas-Tsagli E; Patsouris E
Pathology; 2007 Aug; 39(4):425-32. PubMed ID: 17676485
[TBL] [Abstract][Full Text] [Related]
26. P53 expression as a prognostic marker in giant cell tumor of bone: a pilot study.
Papanastassiou I; Ioannou M; Papagelopoulos PJ; Arealis G; Mihas C; Iakovidou I; Demertzis N
Orthopedics; 2010 May; 33(5):. PubMed ID: 20506947
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
[TBL] [Abstract][Full Text] [Related]
28. [Analyses of p53 mutations in breast cancers with a combined use of yeast functional assay and immunohistochemical staining].
Takahashi M
Hokkaido Igaku Zasshi; 1998 May; 73(3):275-86. PubMed ID: 9719952
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
[TBL] [Abstract][Full Text] [Related]
30. Distribution of p53 mutations in esophageal and gastric carcinomas and the relationship with p53 expression.
Hanazono K; Natsugoe S; Stein HJ; Aikou T; Hoefler H; Siewert JR
Oncol Rep; 2006 Apr; 15(4):821-4. PubMed ID: 16525665
[TBL] [Abstract][Full Text] [Related]
31. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma.
Zhang M; Zhang P; Zhang C; Sun J; Wang L; Li J; Tian Z; Chen W
J Oral Pathol Med; 2009 Mar; 38(3):307-13. PubMed ID: 18710422
[TBL] [Abstract][Full Text] [Related]
33. Topoisomerase II alpha expression in testicular germ cell tumors.
Dimov ND; Zynger DL; Luan C; Kozlowski JM; Yang XJ
Urology; 2007 May; 69(5):955-61. PubMed ID: 17482942
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta1 and regulators of apoptosis.
Sulkowski S; Wincewicz A; Sulkowska M; Koda M
Ann N Y Acad Sci; 2009 Aug; 1171():116-23. PubMed ID: 19723045
[TBL] [Abstract][Full Text] [Related]
35. Expression of glypican 3 in ovarian and extragonadal germ cell tumors.
Zynger DL; Everton MJ; Dimov ND; Chou PM; Yang XJ
Am J Clin Pathol; 2008 Aug; 130(2):224-30. PubMed ID: 18628091
[TBL] [Abstract][Full Text] [Related]
36. Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation.
Houldsworth J; Xiao H; Murty VV; Chen W; Ray B; Reuter VE; Bosl GJ; Chaganti RS
Oncogene; 1998 May; 16(18):2345-9. PubMed ID: 9620551
[TBL] [Abstract][Full Text] [Related]
37. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
Alsner J; Jensen V; Kyndi M; Offersen BV; Vu P; Børresen-Dale AL; Overgaard J
Acta Oncol; 2008; 47(4):600-7. PubMed ID: 18465328
[TBL] [Abstract][Full Text] [Related]
38. Expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with small cell lung cancer.
Lee HW; Han JH; Kim JH; Lee MH; Jeong SH; Kang SY; Choi JH; Oh YT; Park KJ; Hwang SC; Sheen SS; Lim HY
Lung Cancer; 2008 Jan; 59(1):95-104. PubMed ID: 17889401
[TBL] [Abstract][Full Text] [Related]
39. Expression of DNA damage checkpoint protein Hus1 in epithelial ovarian tumors correlates with prognostic markers.
de la Torre J; Gil-Moreno A; García A; Rojo F; Xercavins J; Salido E; Freire R
Int J Gynecol Pathol; 2008 Jan; 27(1):24-32. PubMed ID: 18156970
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
